Figure 3.

Change in overall symptoms league table

Antipsychotics are reported in order of surface under the curve cumulative ranking. Results of the network meta-analysis are presented in the left lower half and results from pairwise meta-analysis in the upper right half, if available. Comparisons between treatments should be read from left to right and the estimate is in the cell in common between the column-defining treatment and the row-defining treatment. In the left lower half, standard mean differences lower than 0 favour the column-defining treatment and in the upper right half, those lower than 0 favour the row-defining treatment. Cells in bold print indicate significant results. NA=not available. AMI=amisulpride. ARI=aripiprazole. ASE=asenapine. BRE=brexpiprazole. CAR=cariprazine. CLO=clozapine. CPX=clopenthixol. CPZ=chlorpromazine. FLU=fluphenazine. FPX=flupentixol. HAL=haloperidol. ILO=iloperidone. LEV=levomepromazine. LOX=loxapine. LUR=lurasidone. MOL=molindone. OLA=olanzapine. PAL=paliperidone. PBO=placebo. PEN=penfluridol. PERA=perazine. PERPH=perphenazine. PIM=pimozide. QUE=quetiapine. RIS=risperidone. SER=sertindole. SUL=sulpiride. THIOR=thioridazine. THIOT=thiotixene. TRIFLU=trifluoperazine. ZIP=ziprasidone. ZOT=zotepine. ZUC=zuclopenthixol.